Cholesterol and Lipoprotein Metabolism Flashcards
What is the basic structure of lipoprotein?
polar surface coat (phospholipid, free cholesterol) and nonpolar lipid core (cholesterol ester, triglyceride) + apolipoproteins (embedded proteins)
Purpose of lipoprotein
transport cholesterol
Difference between triglycerides and phospholipids
phospholipids have 2 FA tails + phosphate –> polar
Lipoproteins with the largest diameter have the highest/lowest density
lowest –> will float (e.g. chylomicrons and chylomicron remants)
Which lipoprotein is it in: ApoB
chylomicrons (48), VLDL, IDL, LDL(100) AKA everything except HDL
Which lipoprotein is it in: ApoA1
HDL
Which lipoprotein is it in:ApoE
VLDL, HDL
Which lipoprotein is it in:ApoCII
chylomicrons, VLDL
Exogenous pathway for lipoprotein metabolism
fats come from intestine –> TG in chylomicrons –> lymph (aka bypass liver) –> lipoprotein lipase in tissues consumes TG –> frees FA for tissues + releases chylomicron remant (w/ApoE)–> LDLR on liver for cholesterol recylcing
What is a required cofactor for lipoprotein lipase?
ApoCII
Endogenous pathway of lipoprotein metabolism
FFA in liver adipose packaged in VLDL (B100) and released to blood –> consumed by LPL –> IDL remnant (intermediate) –> further metabolism to LDL (B100) –> LDLR
How does DM2 or insulin resistance contribute to hyperlipidemia?
increased adipose lipolysis –> higher liver production of TG –> overproduction of VLDL
Why don’t most diabetics have high ldl?
there is often a secondary breakdown in LPL that leaves everything at the VLDL stage
Etiology: Familial chylomicronemia syndrome
mutations in LPL or ApoCII lead to reduced breakdown of chylomicrons and result in chylomicronemia
Presentation of FCS
eruptive xanthomas, pancreatitis
Etiology: Familial dysbetalipoproteinemia
After breakdown of chylomicron, chylomicron remant takes on ApoE which provides docking with the liver (also involved in VLDL remant/IDL uptake)
–> if you have homozyogous ApoE2 instead of 3 or 4, you get buildup of remants of chylomicrons and VLDL
Presentation of FD
xnathomata over elbows, palmar xanthomas, CHD
Etiology: Familial hypercholesterolemia
mutations in LDLR prevent docking of LDL and disrupts cholesterol metabolism –> LDL buildup
can be heterozyogous or homozygous (worse)
Presentation of FH
corneal arcus, xanthelasma, tendon xanthoma (very specific for FH), CHD, normal TG
*significant cutaneous xanthomas in homozyogous FH
What’s the difference between FH and FDB
familial defective apoB-100 involves mutation in apoB in the docking strip for LDLR –> same presentation but different mutation
Etiology: Autosomal dominant hypercholesterolemia 3 (ADH3)
increased pcsk9 negatively regulates LDL receptor
Gain of function or loss of function in Pcsk9 cause severe hypercholesterolemia
gain of function
Etiology: Familial hypertriglyceridemia
VLDL metabolism breaks down
Clinical presentation of FHTG
high VLDL and triglycerides –> if type 5 (severe) severe eruptive xanthomas, pancreatitis, CHD
What is type 5 FHTG?
it is an advanced form that results in high VLDL AND high chylomicrons
Etiology: Familial combined hyperlipidemia FCHL
combined disorder leading to overproduction of VLDL (like in DM2 but have normal LPL) –> high VLDL, high IDL, high LDL
Clinical presentation of FCHL
CHD, high V/I/LDLs
What is Lp(a)
independent risk factor for CHD, highly genetically determined, unknown function, homologous to plasminogen –> bound to ApoB and hangs off the particle
What is the relationship between HDL and CHD?
inverse
HDL structure
TG/CE core with phospholipids + ApoA1
What is the reverse cholesterol transport pathway
HDL interacts with cells like macrophages and promote cholesterol efflux from cells and transports esterified cholesterol back to liver for excretion in bile
Primary genetic causes of low HDL (hypoalphalipoproteinemia)
ApoA1 mutation - rapid catabolism Tangier disease (ABCA1) - cholesterol transport from macrophages to HDL broken down LCAT deficiency - breakdown of cholesterol ester formation in HDL molecules
Is there a causal link between HDL and coronary disease
not clear –> but independent risk factor for CHD risk
Clinical finding in LCAT deficiency
cloudy cholesterol buildup on cornea
Clinical finding in Tangier disease
large orange tonsils